ArticleESMO open2026

Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis.

K Shitara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.